Study: Aspirin Reduces Bowel Cancer Risk by 63 Percent

Two aspirin a day can reduce the risk of colorectal cancer by more than 60 percent, according to a study published in The Lancet medical journal.

The study, which spanned more than a decade, found adults who took 600 milligrams of aspirin daily for at least two years were 63 percent less likely to develop colorectal cancer. All participants were carriers of Lynch syndrome, a genetic condition that predisposes a person to developing certain type of cancers. Although aspirin reduced the risk for developing colorectal cancer, researchers found a similar number of polyps in both groups.

Related Articles on Colorectal Cancer:
Trial Shows First Evidence Anal Cancer is Preventable
Study: Signet Cell Histology Five Times More Likely in Rectal Cancer Patients Under 40
Link Between Colon Cancer and Hot Dogs Questioned

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers